Penile cancer, urethral cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male patients; 2. Aged 18 years or above (non-vulnerable groups); 3. Patients must be able to complete relevant questionnaires under the guidance of medical staff; 4. patients attending the clinic for proposed surgical treatment due to circumcision, prepuce, urethral stenosis, common urological tumours (renal tumours, prostate tumours, urogenital tumours); 5. Patients with penile cancer and urethral cancer who consult the doctor for proposed surgical treatment due to penile swelling, perineal swelling, perineal abscess and scrotal swelling; 6. Patients without serious cardiovascular and cerebrovascular diseases, hepatic and renal insufficiency, haematological system diseases and other patients who are considered unsuitable for chemotherapy by clinicians.
Exclusion criteria
Exclusion criteria: The test group does not meet the diagnostic criteria for penile or urethral cancer, as determined by clinical or pathological examination. The principal investigator or treating physician considers other reasons to be unsuitable for clinical research subjects.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression Free Survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Objective Response Rate;Overall Survival;Drug sensitivity;AEs;Genotyping;Tumor volume and maximum diameter;Key regulatory factors;PDX model tumorigenicity; | — |
Countries
China
Contacts
Shanghai Sixth People’s Hospital